2024 Fall
MCELLBI 120 103 - DIS 103
Therapeutics Discovery and Development
Gabriela Diaz Figueroa
Class #:33548
Units: 4
Instruction Mode:
In-Person Instruction
Offered through
Molecular and Cell Biology
Current Enrollment
Total Open Seats:
-2
Enrolled: 37
Waitlisted: 0
Capacity: 35
Waitlist Max: 5
No Reserved Seats
Hours & Workload
3 hours of instructor presentation of course materials per week, 8 hours of outside work hours per week, and 1 hours of the exchange of opinions or questions on course material per week.
Other classes by Gabriela Diaz Figueroa
Course Catalog Description
This class is designed to introduce students to crucial concepts that underlie the discovery and development of therapeutic modalities. It will cover questions of target discovery and validation; basic properties of therapeutic modalities, such as small molecules, designer proteins, or genome engineering approaches; the design and execution of chemical screens; the medicinal chemistry, pharmacodynamics and -kinetics that is required for drug development; and the steps needed to introduce a new modality into the clinic. Lectures are based on a combination of textbook readings and primary literature and summarized through case studies that highlight critical aspects of drug discovery and development.
Rules & Requirements
Repeat Rules
Course is not repeatable for credit.
Reserved Seats
Current Enrollment
No Reserved Seats
Textbooks & Materials
See class syllabus or https://calstudentstore.berkeley.edu/textbooks for the most current information.
Guide to Open, Free, & Affordable Course Materials